Traded Sep 30, 2026 · Filed Oct 1, 2026
The CFO of Xenon Pharmaceuticals paid $560K out of pocket for Xenon Pharmaceuticals shares. 1 other person at Xenon Pharmaceuticals bought some too, in the same month.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
open market purchase
Code P — open-market or private purchase
~$559,740
Shares × reported transaction price
$500K–$1M
Not enough history to judge
Confirmed open-market purchases by the same insider in the available history
2 distinct insiders in 30 days
Distinct insiders at the same issuer with confirmed open-market purchases
55 days after results of Aug 6, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
None found in footnotes
Only flagged when a footnote says so; never inferred
Traded Sep 30 · filed 1 day later
The CEO of Xenon Pharmaceuticals paid $1.12M out of pocket for Xenon Pharmaceuticals shares. 1 other person at Xenon Pharmaceuticals bought some too, in the same month. The Xenon Pharmaceuticals shares held grew by 151%.